# South Korea Thyroid Test Market

> South Korea Thyroid Test Market Research Report: Size, Share, Trend Analysis By Types (TSH Tests, T4 Tests, T3 Tests, Other) and By End Users (Hospital, Diagnostic Laboratories, Research Laboratories and Institutes) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.34%
- **2024:** $ 44.14 Million
- **2025:** $ 46.94 Million
- **2035:** $ 86.77 Million
- **Key Players:** Abbott Laboratories (US), Roche Diagnostics (CH), Siemens Healthineers (DE), Thermo Fisher Scientific (US), PerkinElmer (US), Bio-Rad Laboratories (US), Ortho Clinical Diagnostics (US), Quest Diagnostics (US)

**Report ID:** MRFR/MED/49856-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-korea-thyroid-test-market-51614

---

## Market Summary

## **South Korea Thyroid Test Market Overview**

As per MRFR analysis, the South Korea Thyroid Test Market Size was estimated at 41.86 (USD Million) in 2023. The South Korea Thyroid Test Market Industry is expected to grow from 44.25(USD Million) in 2024 to 104.25 (USD Million) by 2035. The South Korea Thyroid Test Market CAGR (growth rate) is expected to be around 8.102% during the forecast period (2025 - 2035)

**Key South Korea Thyroid Test Market Trends Highlighted**

The South Korea Thyroid Test Market is experiencing notable trends driven by increasing awareness about thyroid health among the population. This awareness has been significantly enhanced by educational campaigns led by health organizations, aiming to address the rising incidence of thyroid disorders. As more individuals recognize the importance of early diagnosis, there is a growing demand for thyroid testing services. 

This shift is often fueled by the aging population in South Korea, as older individuals are more susceptible to thyroid-related conditions. In addition, the digital transformation in healthcare is providing new opportunities for thyroid tests through telemedicine services and home testing kits, allowing patients greater access and convenience.

In addition, the development of more precise and rapid diagnostic tools, as well as advancements in testing technology, are expected to improve patient care and testing efficiency. This trend is particularly important in a country such as South Korea, where there is a growing emphasis on personalised healthcare solutions and precision medicine. There is a potential for increased partnerships and collaborations between healthcare providers and technology firms to expand the reach and efficacy of thyroid testing in terms of market opportunities. 

These opportunities are also bolstered by the government's dedication to enhancing healthcare access and quality through a variety of initiatives. Furthermore, there is a trend towards preventive healthcare, which implies that a greater number of individuals may elect to undergo routine thyroid screenings as part of their routine health examinations. In general, these trends are indicative of the changing landscape of the South Korean Thyroid Test Market, which is fostering development and meeting the healthcare requirements of the populace.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**South Korea Thyroid Test Market Drivers**

**Increasing Prevalence of Thyroid Disorders**

The rise in thyroid disorders in South Korea is a significant driver for the South Korea Thyroid Test Market Industry. According to the Korean Endocrine Society, the incidence of thyroid disease has been increasing steadily, with recent statistics showing that over 14% of the population is affected by thyroid conditions. This rise is evident in the growing number of patients requiring diagnosis and treatment for hypothyroidism and hyperthyroidism.The high prevalence of these disorders prompts the need for reliable diagnostic tests, thus driving the growth of the Thyroid Test Market. 

Organizations like the Health Insurance Review and Assessment Service have also reported that the number of thyroid function tests conducted annually has doubled in the last decade, indicating a growing recognition and diagnosis of thyroid issues within the healthcare system. Such trends in increasing incidences suggest a robust demand for thyroid testing services and products in South Korea.

**Technological Advancements in Diagnostic Testing**

Advancements in diagnostic technology are significantly propelling the South Korea Thyroid Test Market Industry. The emergence of highly sensitive assays and automated testing systems has improved the accuracy and speed of thyroid testing. For instance, innovations led by firms such as Samsung Medison and CellaVision have enhanced laboratory efficiency and diagnostic capabilities. 

Furthermore, the Ministry of Health and Welfare of South Korea has emphasized investment in Research and Development for new medical technologies, allowing laboratories to adopt sophisticated testing methods.As a result, these advancements have contributed to increasing testing rates and better diagnostic outcomes for patients, thus fueling market growth.

**Government Initiatives and Health Awareness Programs**

Government initiatives aimed at increasing health awareness among the South Korean population are contributing to the growth of the South Korea Thyroid Test Market Industry. The South Korean government has been proactive in promoting health screenings and disease prevention strategies through various campaigns. For example, the 'Thyroid Health Screening Program' introduced in 2022 provides subsidized testing for high-risk populations. 

Such initiatives not only educate the public about thyroid health but also encourage early diagnosis and treatment.Additionally, the Korea Centers for Disease Control and Prevention has reported an increase in participation in screening programs, which correlates with a rise in the demand for thyroid testing services and products, positively affecting the market.

**Rising Geriatric Population**

The growing geriatric population in South Korea is a key driver of the South Korea Thyroid Test Market Industry. According to the Statistics Korea, the elderly population is expected to reach 24% of the total population by 2035, increasing the prevalence of age-related health conditions, including thyroid disorders. 

Older adults are generally more susceptible to hypothyroidism and other thyroid-related diseases, resulting in a higher demand for thyroid testing.Coupled with an awareness of health issues in the older demographic, there is a clear trend towards increased screening and diagnosis, subsequently boosting the market for thyroid testing products and services. Organizations like the Korean Geriatrics Society actively promote awareness among healthcare providers about thyroid health, further enhancing demand in this demographic.

**South Korea Thyroid Test Market Segment Insights**

**Thyroid Test Market Type Insights**

The South Korea Thyroid Test Market, segmented by Type, showcases a diverse landscape with several key testing modalities such as TSH Tests, T4 Tests, T3 Tests, and Others. The TSH test is particularly noteworthy as it plays a critical role in diagnosing thyroid dysfunction, making it a frequent choice among healthcare providers due to its reliability. 

This type of testing not only facilitates early diagnosis but also aids in monitoring treatment efficacy for patients diagnosed with conditions like hypothyroidism and hyperthyroidism. In South Korea, where thyroid problems are increasingly prevalent, the T4 test is vital as it measures thyroxine levels, offering deeper insights about thyroid hormone production.

The importance of the T4 test is underscored by the government's focus on improving healthcare and enhancing public awareness of thyroid diseases, driving higher testing frequency and demand. Furthermore, T3 Tests provide essential data on triiodothyronine hormone levels, which are crucial for understanding metabolism and energy levels among patients. 

This test, although less commonly performed than TSH and T4 tests, serves an important diagnostic function, particularly in complex cases where additional hormonal balance assessments are needed.The "Other" category includes various ancillary tests that further assist healthcare providers in painting a comprehensive picture of a patient's thyroid health, thus catering to specialized cases and supporting personalized treatment approaches. 

Given the rising awareness and medical advancement within the South Korean healthcare sector, coupled with government initiatives focused on chronic disease management, the overall growth prospects remain robust. With a growing aging population who are increasingly susceptible to hormonal imbalances, the South Korea Thyroid Test Market is expected to see continued advancements in testing technologies and methodologies.

Each segment, while having its unique significance, collectively reflects a comprehensive ecosystem that caters to the evolving needs of the healthcare landscape. This broad segmentation not only enhances diagnosis accuracy but also enables tailored treatment plans, improving patient outcomes significantly in South Korea.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Thyroid Test Market End User Insights**

The South Korea Thyroid Test Market is primarily driven by the diverse requirements of its End User segment, including Hospitals, Diagnostic Laboratories, and Research Laboratories and Institutes. Hospitals play a crucial role, providing comprehensive healthcare services, diagnostics, and treatment, making them fundamental in early thyroid disease detection and management. Diagnostic Laboratories are vital as they process a large volume of thyroid testing samples, thus driving efficiency and accuracy in diagnosis, which is essential for effective treatment planning.

Research Laboratories and Institutes contribute significantly to the South Korea Thyroid Test Market by focusing on R&D activities that pave the way for enhanced diagnostic techniques, innovative testing methods, and improved understanding of thyroid disorders. 

Furthermore, the growing prevalence of thyroid-related conditions in South Korea creates a substantial demand across these End User categories, leading to advancements in testing technologies and diagnostic capabilities. Overall, the segmentation highlights the importance of collaboration among these entities to enhance patient outcomes and encourage further developments in the thyroid testing landscape.

**South Korea Thyroid Test Market Key Players and Competitive Insights**

The South Korea Thyroid Test Market is characterized by a competitive landscape reflecting both rapid technological advancements and increasing healthcare demands. The growing prevalence of thyroid disorders, driven by factors such as lifestyle changes and rising awareness among the population, has intensified the focus of various stakeholders in this sector. In addition to conventional laboratory testing, the market has seen advancements in point-of-care testing and molecular diagnostics, which are gaining traction due to their convenience and fast results. 

The competitive dynamics involve a mix of established firms and emerging players vying to capture market share by innovating and expanding their product offerings. Regulatory frameworks also play a critical role in shaping market strategies, influencing everything from testing methodologies to product approvals.Daewoong Pharmaceutical has established a prominent presence in the South Korea Thyroid Test Market. The company boasts a portfolio of advanced diagnostic products that cater specifically to thyroid health. Its strengths in this market stem from its significant investments in research and development, positioning it as a key player capable of bringing innovative products to market. 

The company is also recognized for its strong local partnerships and distribution channels, which enable efficient access to healthcare providers and patients alike. Daewoong Pharmaceutical's strategic approach to maintaining high standards in quality control and customer support has solidified its reputation within the South Korean healthcare landscape, thereby fostering loyalty among healthcare professionals.Seegene has made notable strides in the South Korea Thyroid Test Market, distinguished by its cutting-edge molecular diagnostics capabilities. Known for its unique diagnostic solutions that effectively detect multiple target genes simultaneously, Seegene has positioned itself as a leader in the market for efficient and reliable testing. 

Key products from Seegene include multiplex real-time PCR kits tailored for thyroid function assessments, which are particularly advantageous for healthcare facilities requiring rapid turnaround times. The company continually invests in technological advancements and research, showcasing a strong commitment to innovation. Seegene has actively pursued mergers and acquisitions to enhance its product range and expand its market presence, thereby strengthening its competitive edge in South Korea. Through its focus on high-quality diagnostics and customer-centric solutions, Seegene has positioned itself as a formidable competitor in the SAouth Korea Thyroid Test Market.

**Key Companies in the South Korea Thyroid Test Market Include**

**South Korea Thyroid Test Market Industry Developments**

In recent months, the South Korea Thyroid Test Market has seen significant developments, particularly with rising demand for advanced diagnostic solutions. In September 2023, Daewoong Pharmaceutical announced a partnership with Thermo Fisher Scientific to enhance their diagnostic capabilities, focusing on thyroid tests. Furthermore, Seegene has expanded its product portfolio by introducing high-throughput molecular tests tailored for thyroid disorders, marking a pivotal shift in diagnostic precision. 

The market valuation for companies such as Abbott Laboratories and Roche Diagnostics has surged, influenced by an increase in health awareness and regular screening initiatives by the South Korean government, aimed at early detection of thyroid diseases. In terms of mergers, in June 2023, Becton Dickinson completed its acquisition of a local diagnostics firm to strengthen its foothold in the market. Other companies like BioRad Laboratories and Agilent Technologies continue to innovate, driving growth in point-of-care testing solutions.

The last few years have been significant for the thyroid test market in South Korea, with aggressive Research and Development efforts from major players, fostering a competitive environment and ensuring a robust pipeline of diagnostic tools and technologies.

**South Korea Thyroid Test Market Segmentation Insights**

## Market Drivers

### Advancements in Diagnostic Technologies

Technological innovations in diagnostic testing are transforming the thyroid test market in South Korea. The introduction of advanced testing methodologies, such as high-sensitivity assays and point-of-care testing, is enhancing the accuracy and speed of thyroid function assessments. These advancements not only improve patient outcomes but also streamline the testing process, making it more accessible to a broader population. Moreover, the integration of artificial intelligence and machine learning in diagnostic tools is expected to further refine testing capabilities, allowing for more personalized treatment approaches. As these technologies continue to evolve, the thyroid test market is likely to expand, driven by the demand for more efficient and reliable testing solutions.

### Rising Demand for Preventive Healthcare

The shift towards preventive healthcare in South Korea is significantly influencing the thyroid test market. As individuals become more health-conscious, there is a growing emphasis on early detection of potential health issues, including thyroid disorders. Preventive health screenings are increasingly being integrated into routine healthcare practices, with thyroid tests being a key component. This trend is supported by a cultural shift towards proactive health management, where individuals seek to identify and address health concerns before they escalate. Market data suggests that the preventive healthcare segment is expected to grow at a CAGR of 8% over the next five years, indicating a robust demand for thyroid testing services. Consequently, the thyroid test market is likely to experience substantial growth as more individuals prioritize preventive measures.

### Growing Interest in Personalized Medicine

The increasing focus on personalized medicine is emerging as a significant driver for the thyroid test market. In South Korea, there is a growing recognition of the need for tailored treatment plans based on individual patient profiles, particularly in managing thyroid disorders. This trend is prompting healthcare providers to utilize comprehensive thyroid testing to better understand each patient's unique hormonal balance and genetic predispositions. As a result, the demand for specialized thyroid tests that provide detailed insights into individual health conditions is likely to rise. Market analysts project that the personalized medicine segment will witness a growth rate of approximately 10% annually, indicating a robust opportunity for the thyroid test market to align with this evolving healthcare paradigm.

### Government Initiatives and Health Policies

Government initiatives aimed at improving public health in South Korea play a pivotal role in driving the thyroid test market. The South Korean government has implemented various health policies that promote early detection and management of thyroid disorders. For instance, national health screening programs often include thyroid function tests, which encourage individuals to undergo regular check-ups. These initiatives not only raise awareness but also facilitate access to testing services, thereby increasing the overall testing rates. Additionally, funding for research and development in diagnostic technologies is likely to enhance the accuracy and efficiency of thyroid tests. As a result, the thyroid test market is expected to benefit from these supportive government measures, leading to a more proactive approach to thyroid health among the population.

### Increasing Prevalence of Thyroid Disorders

The rising incidence of thyroid disorders in South Korea is a crucial driver for the thyroid test market. Recent studies indicate that approximately 30% of the population may experience some form of thyroid dysfunction, with conditions such as hypothyroidism and hyperthyroidism becoming increasingly common. This growing prevalence necessitates regular screening and testing, thereby propelling demand for thyroid tests. As awareness of these disorders expands, healthcare providers are likely to recommend more frequent testing, contributing to market growth. Furthermore, the aging population in South Korea, which is projected to reach 20% by 2025, is expected to exacerbate the situation, as older individuals are more susceptible to thyroid-related issues. Consequently, the thyroid test market is poised for significant expansion in response to these demographic shifts.

## Future Outlook

The [Thyroid Test Market](https://www.marketresearchfuture.com/reports/thyroid-test-market-8548) is projected to grow at a 6.34% CAGR from 2025 to 2035, driven by increasing prevalence of thyroid disorders and advancements in diagnostic technologies.

**New opportunities:**

- Development of point-of-care testing devices for rapid diagnosis
- Expansion of telehealth services for remote thyroid monitoring
- Investment in AI-driven analytics for personalized treatment plans

By 2035, the thyroid test market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Type: TSH Tests (Largest) vs. T3 Tests (Fastest-Growing)

In the South Korea thyroid test market, TSH Tests represent the largest segment, dominating the market share due to their widespread use in diagnosing thyroid disorders. T4 Tests follow, contributing significantly to the overall market, while T3 Tests and Other segments hold smaller shares. This distribution indicates a strong preference for TSH Tests among healthcare providers as the go-to option for thyroid testing, emphasizing their importance in patient care. 

The growth trends in this segment are promising, particularly for T3 Tests, which are experiencing increased demand driven by rising awareness of thyroid health and the importance of hormone-level testing. Innovative testing technologies and better accessibility in urban areas are further propelling the growth of T3 Tests. TSH Tests are expected to remain essential, supported by ongoing research and the integration of advanced diagnostic tools.

TSH Tests (Dominant) vs. T3 Tests (Emerging)

TSH Tests have established themselves as the dominant segment in the South Korea thyroid test market, largely due to their critical role in diagnosing thyroid dysfunctions. Their reliability and efficiency have made them a standard procedure in clinical settings, ensuring consistent demand. In contrast, T3 Tests are emerging, gaining traction as healthcare providers recognize their value in comprehensive thyroid assessments. As the market evolves, the advancements in the sensitivity and specificity of T3 testing are driving wider adoption, with healthcare practitioners increasingly advocating for thorough thyroid evaluations. This dynamic presents both challenges and opportunities, as the market adapts to evolving healthcare needs and patient preferences.

### By End-User: Hospital (Largest) vs. Diagnostic Laboratories (Fastest-Growing)

In the South Korea thyroid test market, the distribution of end-user segments reveals hospitals as the largest contributor, securing a significant share due to their extensive patient network and comprehensive facilities. Diagnostic laboratories follow closely, capturing a notable market portion, especially as they expand capabilities and partnerships to enhance service offerings.

Growth trends indicate a shift towards an increasing reliance on diagnostic laboratories, which are becoming the fastest-growing segment as they innovate and adopt advanced testing technologies. The rise in healthcare awareness and preventive screening drives the demand for thyroid testing, particularly in outpatient settings, leading to a more pronounced role for diagnostic facilities in routine patient care.

Hospital (Dominant) vs. Diagnostic Laboratories (Emerging)

Hospitals serve as the dominant end-user segment within the South Korea thyroid test market, primarily due to their established infrastructure and wide-ranging medical services. They offer an all-inclusive approach to patient care, encompassing diagnosis, treatment, and follow-up, making them pivotal in managing thyroid diseases. Conversely, diagnostic laboratories are emerging robustly, focusing on specialized testing and quicker turnaround times. Their adaptability to the latest diagnostic technologies and collaborations with healthcare providers position them well to cater to the increasing demand for thyroid screening. This shift towards more specialized care reflects broader trends in the healthcare system, emphasizing personalized diagnostics and enhanced patient access.

## Competitive Benchmarking

The thyroid test market exhibits a dynamic competitive landscape, characterized by a blend of innovation and strategic partnerships among key players. Major companies such as Abbott Laboratories (US), Roche Diagnostics (CH), and Siemens Healthineers (DE) are at the forefront, leveraging their technological prowess to enhance diagnostic accuracy and patient outcomes. Abbott Laboratories (US) focuses on expanding its product portfolio through innovative testing solutions, while Roche Diagnostics (CH) emphasizes strategic collaborations to enhance its market reach. Siemens Healthineers (DE) appears to be investing heavily in digital transformation, integrating advanced analytics into its testing processes, which collectively shapes a competitive environment that prioritizes technological advancement and patient-centric solutions.Key business tactics within the market include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The competitive structure is moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they set industry standards and drive innovation. This competitive interplay fosters an environment where smaller firms may struggle to keep pace, yet it also encourages collaboration and partnerships that can lead to enhanced product offerings and market penetration.

In October  Roche Diagnostics (CH) announced a strategic partnership with a leading South Korean healthcare provider to enhance the accessibility of its thyroid testing solutions. This collaboration is poised to improve patient access to advanced diagnostic tools, thereby potentially increasing Roche's market share in the region. The strategic importance of this partnership lies in its ability to leverage local expertise and distribution networks, which could significantly enhance Roche's operational efficiency and market responsiveness.

In September  Siemens Healthineers (DE) launched a new AI-driven thyroid testing platform aimed at improving diagnostic accuracy and reducing turnaround times. This innovation is particularly noteworthy as it aligns with the growing trend towards digitalization in healthcare. The introduction of AI capabilities not only enhances Siemens' competitive edge but also reflects a broader industry shift towards integrating technology into traditional diagnostic processes, which may redefine patient care standards.

In August  Abbott Laboratories (US) expanded its manufacturing capabilities in South Korea, focusing on the production of its latest thyroid testing kits. This move is strategically significant as it not only localizes production but also aims to meet the increasing demand for rapid and accurate testing solutions. By enhancing its manufacturing footprint, Abbott positions itself to respond more swiftly to market needs, thereby strengthening its competitive position in the region.

As of November  current trends in the thyroid test market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in navigating complex market dynamics. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of agility and responsiveness in meeting the evolving needs of healthcare providers and patients alike.

## Recent News & Developments

In recent months, the South Korea Thyroid Test Market has seen significant developments, particularly with rising demand for advanced diagnostic solutions. In September 2023, Daewoong Pharmaceutical announced a partnership with Thermo Fisher Scientific to enhance their diagnostic capabilities, focusing on thyroid tests. Furthermore, Seegene has expanded its product portfolio by introducing high-throughput molecular tests tailored for thyroid disorders, marking a pivotal shift in diagnostic precision. 

The market valuation for companies such as Abbott Laboratories and Roche Diagnostics has surged, influenced by an increase in health awareness and regular screening initiatives by the South Korean government, aimed at early detection of thyroid diseases. In terms of mergers, in June 2023, Becton Dickinson completed its acquisition of a local diagnostics firm to strengthen its foothold in the market. Other companies like BioRad Laboratories and Agilent Technologies continue to innovate, driving growth in point-of-care testing solutions.

The last few years have been significant for the thyroid test market in South Korea, with aggressive Research and Development efforts from major players, fostering a competitive environment and ensuring a robust pipeline of diagnostic tools and technologies.

## Report Scope

| MARKET SIZE 2024 | 44.14 (USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 46.94 (USD Million) |
| MARKET SIZE 2035 | 86.77 (USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.34% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Abbott Laboratories (US), Roche Diagnostics (CH), Siemens Healthineers (DE), Thermo Fisher Scientific (US), PerkinElmer (US), Bio-Rad Laboratories (US), Ortho Clinical Diagnostics (US), Quest Diagnostics (US) |
| Segments Covered | Type, End-User |
| Key Market Opportunities | Integration of advanced diagnostic technologies enhances accuracy in the thyroid test market. |
| Key Market Dynamics | Rising demand for thyroid testing driven by increased awareness and advancements in diagnostic technologies. |
| Countries Covered | South Korea |

## Frequently Asked Questions

**Q: What was the overall market valuation of the thyroid test market in 2024?**
A: The overall market valuation was $44.14 Million in 2024.

**Q: What is the projected market valuation for the thyroid test market by 2035?**
A: The projected valuation for 2035 is $86.77 Million.

**Q: What is the expected CAGR for the thyroid test market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during the forecast period is 6.34%.

**Q: Which companies are considered key players in the thyroid test market?**
A: Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific.

**Q: What are the main segments of the thyroid test market by type?**
A: The main segments by type include TSH Tests, T4 Tests, T3 Tests, and Other.

**Q: What were the valuations for TSH Tests in 2024?**
A: The valuations for TSH Tests ranged from $15.0 Million to $30.0 Million in 2024.

**Q: How do diagnostic laboratories contribute to the thyroid test market?**
A: Diagnostic Laboratories contributed between $20.0 Million and $40.0 Million in 2024.

**Q: What is the valuation range for T4 Tests in 2024?**
A: The valuation range for T4 Tests in 2024 was between $10.0 Million and $20.0 Million.

**Q: What is the expected growth trend for research laboratories in the thyroid test market?**
A: Research Laboratories & Institutes had a valuation range of $9.14 Million to $16.77 Million in 2024, indicating potential growth.

**Q: What is the significance of the thyroid test market's growth from 2024 to 2035?**
A: The growth from $44.14 Million in 2024 to $86.77 Million in 2035 suggests a robust expansion in the thyroid test market.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-thyroid-test-market-51614*